{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:52:49Z","timestamp":1791910369691,"version":"4.3.4"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.vaccine.2026.129205","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:17:38Z","timestamp":1790857058000},"page":"129205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["An integrated immunoinformatics and experimental pipeline identifies an LCL-scaffolded OmpA loop 3 construct as a protective vaccine candidate against Acinetobacter baumannii"],"prefix":"10.1016","volume":"93","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-1611-5718","authenticated-orcid":false,"given":"Seyyedeh Reyhaneh","family":"Banisaeed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0530-4324","authenticated-orcid":false,"given":"Iraj","family":"Rasooli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1049-7095","authenticated-orcid":false,"given":"Tooba","family":"Ghazanfari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5052-2523","authenticated-orcid":false,"given":"Soheila","family":"Ajdary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6540-1003","authenticated-orcid":false,"given":"Vajihe Sadat","family":"Nikbin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.129205_bb0005","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1053968","article-title":"Deciphering the virulence factors, regulation, and immune response to Acinetobacter baumannii infection","volume":"13","author":"Shadan","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"3","key":"10.1016\/j.vaccine.2026.129205_bb0010","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect. Dis."},{"issue":"7","key":"10.1016\/j.vaccine.2026.129205_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiph.2026.103264","article-title":"Old drugs, new lifelines: an update on drug repurposing against multidrug-resistant Acinetobacter baumannii","volume":"19","author":"Saany","year":"2026","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.vaccine.2026.129205_bb0020","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.micpath.2017.02.028","article-title":"In silico design of an immunogen against Acinetobacter baumannii based on a novel model for native structure of outer membrane protein a","volume":"105","author":"Jahangiri","year":"2017","journal-title":"Microb. Pathog."},{"issue":"3","key":"10.1016\/j.vaccine.2026.129205_bb0025","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1021\/acsinfecdis.7b00168","article-title":"Acinetobacter baumannii OmpA is a selective antibiotic permeant porin","volume":"4","author":"Iyer","year":"2017","journal-title":"ACS Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129205_bb0030","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12929-020-0617-7","article-title":"Outer membrane protein a (OmpA) as a potential therapeutic target for Acinetobacter baumannii infection","volume":"27","author":"Nie","year":"2020","journal-title":"J. Biomed. Sci."},{"issue":"1","key":"10.1016\/j.vaccine.2026.129205_bb0035","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1038\/s41598-021-81356-8","article-title":"Specific egg yolk immunoglobulin as a promising non-antibiotic biotherapeutic product against Acinetobacter baumannii pneumonia infection","volume":"11","author":"Jahangiri","year":"2021","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.vaccine.2026.129205_bb0040","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/jam.14135","article-title":"Specific egg yolk antibodies (IgY) confer protection against Acinetobacter baumannii in a murine pneumonia model","volume":"126","author":"Jahangiri","year":"2019","journal-title":"J. Appl. Microbiol."},{"issue":"2","key":"10.1016\/j.vaccine.2026.129205_bb0045","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.vaccine.2012.11.008","article-title":"Acinetobacter baumannii rOmpA vaccine dose alters immune polarization and immunodominant epitopes","volume":"31","author":"Lin","year":"2013","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129205_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029446","article-title":"Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infection","volume":"7","author":"Luo","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2026.129205_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2023.106262","article-title":"A two-protein cocktail elicits a protective immune response against Acinetobacter baumannii in a murine infection model","volume":"182","author":"Mirali","year":"2023","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.vaccine.2026.129205_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2022.105874","article-title":"Combination of BauA and OmpA elicit immunoprotection against Acinetobacter baumannii in a murine sepsis model","volume":"173","author":"Tamehri","year":"2022","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.vaccine.2026.129205_bb0065","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.micpath.2016.04.019","article-title":"Mucosal immunization with purified OmpA elicited protective immunity against infections caused by multidrug-resistant Acinetobacter baumannii","volume":"96","author":"Zhang","year":"2016","journal-title":"Microb. Pathog."},{"issue":"1","key":"10.1016\/j.vaccine.2026.129205_bb0070","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-79966-9","article-title":"Outer membrane vesicles containing OmpA induce mitochondrial fragmentation to promote pathogenesis of Acinetobacter baumannii","volume":"11","author":"Tiku","year":"2021","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.vaccine.2026.129205_bb0075","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12865-025-00766-9","article-title":"OmpA virulence factor, a promising conserved vaccine candidate against Acinetobacter baumannii, could trigger autoreactive immune responses in susceptible population","volume":"26","author":"Zanoos","year":"2025","journal-title":"BMC Immunol."},{"issue":"2324","key":"10.1016\/j.vaccine.2026.129205_bb0080","doi-asserted-by":"crossref","first-page":"w20052","DOI":"10.4414\/smw.2019.20052","article-title":"Design and evaluation of a multi-epitope assembly peptide vaccine against Acinetobacter baumannii infection in mice","volume":"149","author":"Ren","year":"2019","journal-title":"Swiss Med. Wkly."},{"key":"10.1016\/j.vaccine.2026.129205_bb0085","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.933445","article-title":"Hybrid antigens expressing surface loops of BauA from Acinetobacter baumannii are capable of inducing protection against infection","volume":"13","author":"Chaudhuri","year":"2022","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.vaccine.2026.129205_bb0090","article-title":"Designing a novel peptide-based multi-epitope vaccine to evoke a robust immune response against pathogenic multidrug-resistant Providencia heimbachae","volume":"10","author":"Naveed","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"10","key":"10.1016\/j.vaccine.2026.129205_bb0095","article-title":"Immunoinformatics approach to design multi-epitope-based vaccine against Machupo virus taking viral nucleocapsid as a potential candidate","volume":"10","author":"Naveed","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"P04585","key":"10.1016\/j.vaccine.2026.129205_bb0100","first-page":"345","article-title":"A reverse vaccinology approach to design an mRNA-based vaccine to provoke a robust immune response against HIV-1","volume":"9","author":"Naveed","year":"2025","journal-title":"Acta Biochimica Polonica (ABP)"},{"issue":"11","key":"10.1016\/j.vaccine.2026.129205_bb0105","doi-asserted-by":"crossref","first-page":"18139","DOI":"10.1007\/s00210-026-05493-5","article-title":"Immunopharmacologsical and structural insights into Rift Valley fever virus envelope glycoproteins: an immunoinformatics approach to multi-epitope vaccine design","volume":"399","author":"Aziz","year":"2026","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"issue":"11","key":"10.1016\/j.vaccine.2026.129205_bb0110","doi-asserted-by":"crossref","first-page":"18423","DOI":"10.1007\/s00210-026-05534-z","article-title":"Immunopharmacological design of a multi-epitope vaccine targeting sarbecovirus spike glycoprotein","volume":"399","author":"Aziz","year":"2026","journal-title":"Naunyn Schmiedeberg\u2019s Arch. Pharmacol."},{"issue":"1","key":"10.1016\/j.vaccine.2026.129205_bb0115","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1038\/s41598-025-88191-1","article-title":"Fragment optimized chalcone derivatives targeting OmpA protein as a therapeutic approach against multidrug resistant Acinetobacter baumannii","volume":"15","author":"Naveed","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.vaccine.2026.129205_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113066","article-title":"In silico design of a novel hybrid epitope-based antigen harboring highly exposed immunogenic peptides of BamA, OmpA, and Omp34 against Acinetobacter baumannii","volume":"142","author":"Hessami","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.vaccine.2026.129205_bb0125","doi-asserted-by":"crossref","first-page":"10852","DOI":"10.1038\/s41598-022-14877-5","article-title":"A unique antigen against SARS-CoV-2, Acinetobacter baumannii, and Pseudomonas aeruginosa","volume":"12","author":"Rahbar","year":"2022","journal-title":"Sci. Rep."},{"issue":"15","key":"10.1016\/j.vaccine.2026.129205_bb0130","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1128\/JB.00435-12","article-title":"OmpA is the principal nonspecific slow porin of Acinetobacter baumannii","volume":"194","author":"Sugawara","year":"2012","journal-title":"J. Bacteriol."},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2026.129205_bb0135","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.vetmic.2012.08.019","article-title":"The OmpA family of proteins: roles in bacterial pathogenesis and immunity","volume":"163","author":"Confer","year":"2013","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.vaccine.2026.129205_bb0140","series-title":"Glycosyltransferases involved in the glycosylation of serine-rich glycoproteins from Streptococci","author":"Zhu","year":"2016"},{"key":"10.1016\/j.vaccine.2026.129205_bb0145","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00247","article-title":"Utility of hybrid transferrin binding protein antigens for protection against pathogenic Neisseria species","volume":"10","author":"Fegan","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.vaccine.2026.129205_bb0150","series-title":"Bacterial vaccines: Methods and protocols","first-page":"115","article-title":"Design and production of hybrid antigens for targeting integral outer membrane proteins in gram-negative bacteria","author":"Chaudhuri","year":"2021"},{"key":"10.1016\/j.vaccine.2026.129205_bb0155","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00158","article-title":"Hybrid antigens expressing surface loops of ZnuD from Acinetobacter baumannii is capable of inducing protection against infection","volume":"11","author":"Qamsari","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.vaccine.2026.129205_bb0160","doi-asserted-by":"crossref","DOI":"10.1186\/1745-7580-2-2","article-title":"Improved method for predicting linear B-cell epitopes","volume":"2","author":"Larsen","year":"2006","journal-title":"Immunome Res."},{"issue":"W1","key":"10.1016\/j.vaccine.2026.129205_bb0165","doi-asserted-by":"crossref","first-page":"W24","DOI":"10.1093\/nar\/gkx346","article-title":"BepiPred-2.0: improving sequence-based B-cell epitope prediction using conformational epitopes","volume":"45","author":"Jespersen","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.vaccine.2026.129205_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062216","article-title":"Improved method for linear B-cell epitope prediction using antigen\u2019s primary sequence","volume":"8","author":"Singh","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129205_bb0175","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/prot.21078","article-title":"Prediction of continuous B\u2010cell epitopes in an antigen using recurrent neural network","volume":"65","author":"Saha","year":"2006","journal-title":"Proteins"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129205_bb0180","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2105-8-4","article-title":"VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines","volume":"8","author":"Doytchinova","year":"2007","journal-title":"BMC Bioinformatics"},{"issue":"6","key":"10.1016\/j.vaccine.2026.129205_bb0185","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1007\/s00894-014-2278-5","article-title":"AllerTOP v. 2\u2014a server for in silico prediction of allergens","volume":"20","author":"Dimitrov","year":"2014","journal-title":"J. Mol. Model."},{"issue":"9","key":"10.1016\/j.vaccine.2026.129205_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073957","article-title":"In silico approach for predicting toxicity of peptides and proteins","volume":"8","author":"Gupta","year":"2013","journal-title":"PLoS One"},{"issue":"17","key":"10.1016\/j.vaccine.2026.129205_bb0195","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1093\/bioinformatics\/btp386","article-title":"SOLpro: accurate sequence-based prediction of protein solubility","volume":"25","author":"Magnan","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.vaccine.2026.129205_bb0200","series-title":"The proteomics protocols handbook","first-page":"571","article-title":"Protein identification and analysis tools on the ExPASy server","author":"Gasteiger","year":"2005"},{"issue":"3","key":"10.1016\/j.vaccine.2026.129205_bb0205","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00726-006-0485-9","article-title":"Prediction of linear B-cell epitopes using amino acid pair antigenicity scale","volume":"33","author":"Chen","year":"2007","journal-title":"Amino Acids"},{"key":"10.1016\/j.vaccine.2026.129205_bb0210","article-title":"Porter 5: state-of-the-art ab initio prediction of protein secondary structure in 3 and 8 classes","author":"Torrisi","year":"2018","journal-title":"bioRxiv"},{"issue":"4","key":"10.1016\/j.vaccine.2026.129205_bb0215","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jmb.2014.12.007","article-title":"The s2D method: simultaneous sequence-based prediction of the statistical populations of ordered and disordered regions in proteins","volume":"427","author":"Sormanni","year":"2015","journal-title":"J. Mol. Biol."},{"issue":"5","key":"10.1016\/j.vaccine.2026.129205_bb0220","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.compbiolchem.2004.09.005","article-title":"The influence of gapped positions in multiple sequence alignments on secondary structure prediction methods","volume":"28","author":"Simossis","year":"2004","journal-title":"Comput. Biol. Chem."},{"issue":"W1","key":"10.1016\/j.vaccine.2026.129205_bb0225","doi-asserted-by":"crossref","first-page":"W389","DOI":"10.1093\/nar\/gkv332","article-title":"JPred4: a protein secondary structure prediction server","volume":"43","author":"Drozdetskiy","year":"2015","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.vaccine.2026.129205_bb0230","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nmeth.3213","article-title":"The I-TASSER suite: protein structure and function prediction","volume":"12","author":"Yang","year":"2015","journal-title":"Nat. Methods"},{"issue":"W1","key":"10.1016\/j.vaccine.2026.129205_bb0235","doi-asserted-by":"crossref","first-page":"W296","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: homology modelling of protein structures and complexes","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"W1","key":"10.1016\/j.vaccine.2026.129205_bb0240","doi-asserted-by":"crossref","first-page":"W454","DOI":"10.1093\/nar\/gkac248","article-title":"LOMETS3: integrating deep learning and profile alignment for advanced protein template recognition and function annotation","volume":"50","author":"Zheng","year":"2022","journal-title":"Nucleic Acids Res."},{"issue":"12","key":"10.1016\/j.vaccine.2026.129205_bb0245","doi-asserted-by":"crossref","first-page":"5634","DOI":"10.1038\/s41596-021-00628-9","article-title":"The trRosetta server for fast and accurate protein structure prediction","volume":"16","author":"Du","year":"2021","journal-title":"Nat. Protoc."},{"issue":"2","key":"10.1016\/j.vaccine.2026.129205_bb0250","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1107\/S0021889892009944","article-title":"PROCHECK: a program to check the stereochemical quality of protein structures","volume":"26","author":"Laskowski","year":"1993","journal-title":"J. Appl. Crystallogr."},{"issue":"9","key":"10.1016\/j.vaccine.2026.129205_bb0255","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1002\/pro.5560020916","article-title":"Verification of protein structures: patterns of nonbonded atomic interactions","volume":"2","author":"Colovos","year":"1993","journal-title":"Protein Sci."},{"issue":"suppl_2","key":"10.1016\/j.vaccine.2026.129205_bb0260","doi-asserted-by":"crossref","first-page":"W407","DOI":"10.1093\/nar\/gkm290","article-title":"ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins","volume":"35","author":"Wiederstein","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.vaccine.2026.129205_bb0265","first-page":"1","article-title":"Prediction of protein structure and interaction by GALAXY protein modeling programs","volume":"2","author":"HeeShin","year":"2014","journal-title":"Biodesign"},{"issue":"3","key":"10.1016\/j.vaccine.2026.129205_bb0270","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1021\/ct700301q","article-title":"GROMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation","volume":"4","author":"Hess","year":"2008","journal-title":"J. Chem. Theory Comput."},{"issue":"1","key":"10.1016\/j.vaccine.2026.129205_bb0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2105-9-514","article-title":"ElliPro: a new structure-based tool for the prediction of antibody epitopes","volume":"9","author":"Ponomarenko","year":"2008","journal-title":"BMC Bioinformatics"},{"issue":"2","key":"10.1016\/j.vaccine.2026.129205_bb0280","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nprot.2016.169","article-title":"The ClusPro web server for protein\u2013protein docking","volume":"12","author":"Kozakov","year":"2017","journal-title":"Nat. Protoc."},{"issue":"1","key":"10.1016\/j.vaccine.2026.129205_bb0285","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/pro.3289","article-title":"PDBsum: structural summaries of PDB entries","volume":"27","author":"Laskowski","year":"2018","journal-title":"Protein Sci."},{"issue":"W1","key":"10.1016\/j.vaccine.2026.129205_bb0290","doi-asserted-by":"crossref","first-page":"W432","DOI":"10.1093\/nar\/gkad376","article-title":"PEP-FOLD4: a pH-dependent force field for peptide structure prediction in aqueous solution","volume":"51","author":"Rey","year":"2023","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.vaccine.2026.129205_bb0295","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1038\/s41596-020-0312-x","article-title":"The HDOCK server for integrated protein\u2013protein docking","volume":"15","author":"Yan","year":"2020","journal-title":"Nat. Protoc."},{"issue":"2","key":"10.1016\/j.vaccine.2026.129205_bb0300","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/protein\/8.2.127","article-title":"LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions","volume":"8","author":"Wallace","year":"1995","journal-title":"Protein Eng. Des. Sel."},{"issue":"4","key":"10.1016\/j.vaccine.2026.129205_bb0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009862","article-title":"Computational immunology meets bioinformatics: the use of prediction tools for molecular binding in the simulation of the immune system","volume":"5","author":"Rapin","year":"2010","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.vaccine.2026.129205_bb0310","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2144\/000114017","article-title":"Gene splicing by overlap extension: tailor-made genes using the polymerase chain reaction","volume":"54","author":"Horton","year":"2013","journal-title":"Biotechniques"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129205_bb0315","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"issue":"1","key":"10.1016\/j.vaccine.2026.129205_bb0320","doi-asserted-by":"crossref","first-page":"6G.3.1","DOI":"10.1002\/cpmc.36","article-title":"Mouse models of Acinetobacter baumannii infection","volume":"46","author":"Harris","year":"2017","journal-title":"Curr Protoc Microbiol"},{"key":"10.1016\/j.vaccine.2026.129205_bb0325","article-title":"Toxoplasma gondii elongation factor 1-alpha (TgEF-1\u03b1) is a novel vaccine candidate antigen against toxoplasmosis","volume":"8","author":"Wang","year":"2017","journal-title":"Front. Microbiol."},{"issue":"6","key":"10.1016\/j.vaccine.2026.129205_bb0330","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ijantimicag.2015.03.001","article-title":"Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: mechanisms and epidemiology","volume":"45","author":"Potron","year":"2015","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"16","key":"10.1016\/j.vaccine.2026.129205_bb0335","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1517\/14656566.2012.729820","article-title":"Therapeutic options for Acinetobacter baumannii infections: an update","volume":"13","author":"Vila","year":"2012","journal-title":"Expert. Opin. Pharmacother."},{"issue":"2","key":"10.1016\/j.vaccine.2026.129205_bb0340","doi-asserted-by":"crossref","first-page":"174","DOI":"10.5455\/javar.2019.f329","article-title":"Epitope-based vaccine as a universal vaccination strategy against toxoplasma gondii infection: a mini-review","volume":"6","author":"Hajissa","year":"2019","journal-title":"Journal of Advanced Veterinary and Animal Research"},{"issue":"9","key":"10.1016\/j.vaccine.2026.129205_bb0345","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph19095568","article-title":"Vaccinomics to design a multi-epitopes vaccine for Acinetobacter baumannii","volume":"19","author":"Ud-Din","year":"2022","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.vaccine.2026.129205_bb0350","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1088130","article-title":"Subunit vaccines for Acinetobacter baumannii","volume":"13","author":"Yang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.vaccine.2026.129205_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108731","article-title":"BauA and Omp34 surface loops trigger protective antibodies against Acinetobacter baumannii in a murine sepsis model","volume":"108","author":"Akbari","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.vaccine.2026.129205_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109013","article-title":"Immunogenicity of loop 3 of Omp34 from a. Baumannii in loopless C-lobe of TbpB of N. Meningitidis","volume":"110","author":"Golestani","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"6","key":"10.1016\/j.vaccine.2026.129205_bb0365","article-title":"In silico design and evaluation of Acinetobacter baumannii outer membrane protein a (OmpA) antigenic peptides as vaccine candidate in immunized mice","volume":"18","author":"Mehdinejadiani","year":"2019","journal-title":"Iran J Allergy Asthma Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2026.129205_bb0370","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s13258-025-01656-5","article-title":"In silico screening of epitopes as potential vaccine candidates against pathogenic Acinetobacter baumannii","volume":"47","author":"Islam","year":"2025","journal-title":"Genes and genomics"},{"issue":"14","key":"10.1016\/j.vaccine.2026.129205_bb0375","doi-asserted-by":"crossref","first-page":"12683","DOI":"10.1074\/jbc.M110.206102","article-title":"Structural variations within the transferrin binding site on transferrin-binding protein B, TbpB","volume":"286","author":"Calmettes","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"7491","key":"10.1016\/j.vaccine.2026.129205_bb0380","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nature12966","article-title":"Proof of principle for epitope-focused vaccine design","volume":"507","author":"Correia","year":"2014","journal-title":"Nature"},{"issue":"42","key":"10.1016\/j.vaccine.2026.129205_bb0385","doi-asserted-by":"crossref","first-page":"17880","DOI":"10.1073\/pnas.1004728107","article-title":"Elicitation of structure-specific antibodies by epitope scaffolds","volume":"107","author":"Ofek","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.vaccine.2026.129205_bb0390","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1271143","article-title":"A new candidate epitope-based vaccine against PspA PhtD of Streptococcus pneumoniae: a computational experimental approach","volume":"13","author":"Shafaghi","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.vaccine.2026.129205_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.128924","article-title":"Design, development, and assessment of a novel multi-peptide vaccine targeting PspC, PsaA, and PhtD proteins of Streptococcus pneumoniae","volume":"258","author":"Bahadori","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.vaccine.2026.129205_bb0400","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1186\/s12967-022-03590-6","article-title":"In silico designing of a novel epitope-based candidate vaccine against Streptococcus pneumoniae with introduction of a new domain of PepO as adjuvant","volume":"20","author":"Bahadori","year":"2022","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.vaccine.2026.129205_bb0405","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12859-023-05175-6","article-title":"Immunoinformatics-aided design of a new multi-epitope vaccine adjuvanted with domain 4 of pneumolysin against Streptococcus pneumoniae strains","volume":"24","author":"Shafaghi","year":"2023","journal-title":"BMC Bioinformatics"},{"issue":"5","key":"10.1016\/j.vaccine.2026.129205_bb0410","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.immuni.2011.05.006","article-title":"Toll-like receptors and their crosstalk with other innate receptors in infection and immunity","volume":"34","author":"Kawai","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2026.129205_bb0415","doi-asserted-by":"crossref","first-page":"26","DOI":"10.29328\/journal.ijcmbt.1001012","article-title":"Role of T-helper cells (CD4+ T cells) in human immune system against some microbial infection: a mini review","volume":"3","author":"Ali","year":"2020","journal-title":"Int J Clin Microbiol Biochem Technol"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129205_bb0420","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1086\/317537","article-title":"Type 1\/type 2 immunity in infectious diseases","volume":"32","author":"Spellberg","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.vaccine.2026.129205_bb0425","article-title":"Bioinformatics analysis and consistency verification of a novel tuberculosis vaccine candidate HP13138PB","volume":"14","author":"Cheng","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.vaccine.2026.129205_bb0430","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1080\/22221751.2022.2122585","article-title":"Development and evaluation of a multi-epitope subunit vaccine against group B Streptococcus infection","volume":"11","author":"Zhang","year":"2022","journal-title":"Emerg Microbes Infect"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26010145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26010145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:24:01Z","timestamp":1791908641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26010145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":86,"alternative-id":["S0264410X26010145"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129205","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An integrated immunoinformatics and experimental pipeline identifies an LCL-scaffolded OmpA loop 3 construct as a protective vaccine candidate against Acinetobacter baumannii","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129205","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"129205"}}